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ABSTRACT
HPA-AXIS REACTIVITY TO INTERPERSONAL STRESS IN YOUNG ADULTS
WHO SELF-INJURE
SEPTEMBER 2003
ELIZA T. MCARDLE, B.A., WELLESLEY COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Sally I. Powers
The purpose of this study was to examine HPA-axis functioning in a non-patient
sample of self-injurious adolescents in response to an interpersonal stressor. Salivary
cortisol levels were measured two times prior to and five times following an interpersonal
stressor as markers of HPA-axis reactivity. Women exclusively show a positive relation
between self-injurious behavior and the rate at which they reach peak cortisol levels.
Both trauma symptoms and depressive symptoms are shown to moderate the relations
between self-injurious behavior and cortisol levels in women. Men show no association
between these factors, perhaps indicating different processes behind and reasons for self-
injurious behavior. These results have implications for theories of etiology, development,
maintenance, and treatment of self-injurious behavior in patient populations and in the
general public.
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CHAPTER 1
INTRODUCTION
Self-injurious Behavior (SIB) is a highly disturbing behavior that has been, until
recently, poorly understood. Much of the current research on SIB has focused on the
psychological functions and precipitants, as well as the etiological factors leading to self-
injury. However, surprisingly little research has explored the physiological dysregulation
that characterizes those individuals who engage in physical damage to themselves. SIB's
occurrence is well documented within several populations, including individuals with
severe mental retardation and autistic disorders, individuals with psychotic spectrum
disorders, and people with severe personality and affective disorders (Favazza, 1996)
Unfortunately it is becoming more evident that both men and women without diagnosed
psychological disorders engage in SIB as well (Favazza, 1998). While the functions and
meanings of self-injurious behavior are fairly well understood, very little is known about
the physiological make-up, or dysregulation, in people who engage in this behavior
In order to explore potential physiological dysregulation in SIB, it is first
necessary to understand how SIB is defined in the psychological literature Self-injurious
behavior (also called self-mutilation) has been variously categorized and
described by
different authors over the past 15 years (Favazza, 1996; Pao, 1969, Pattison & Kahan,
1983, Walsh & Rosen, 1988). Currently, the best cited of these typologies are those by
Walsh and Rosen (1988) and Favazza (1996).
Categorization of Self-lniurious Behavior
Walsh and Rosen categorize self-injurious behavior into four types, taking into
consideration the degree of physical damage, the psychological state under which the
behavior was performed, and the social acceptability of the behavior Type 1 SIB
represents the least damaging and most socially acceptable forms of behavior that are
performed while the individual is in a “benign” psychological state These behaviors
include ear piercing, nail biting, and professionally applied tattoos Type II SIB involves
mild to moderate damage of the body, is acceptable in various subcultures of our society,
and is performed in either a benign or agitated psychological state. Behaviors within this
category include radical piercings, scarification, and large body covering tattoos. Type
III SIB, the form of self-injury examined in this study, is associated with mild to
moderate physical damage, is generally unacceptable within our society, and is
performed in a state of psychic crisis. Behaviors such as these include wrist and body
cutting or scratching, self-inflicted burns, intentional self-bruising, and intentional
ingestion of poisonous substances. Finally, Type IV SIB, according to Walsh and Rosen
(1988) causes severe bodily damage, is performed while in a psychotic state and is
entirely unacceptable in all social groups. Behaviors that fit into this category are
extremely rare even within an inpatient population and include injuries such as self-
amputation, auto castration, or eye enucleation.
In another system, Favazza (1996) separates self-mutilation into two major
categories, specifying sub-types within each category. He points out that
SIB can be
separated into either culturally sanctioned (scarification
within certain religious or
spiritual rituals) or pathological categories. He further separates the
pathological form of
SIB into three major subtypes: Major, Stereotypic, and Moderate/superficial. Major
pathological SIB, according to Favazza (1996), fits into Walsh and Rosen’s “Type IV”
category, while the “moderate/superficial” subtype corresponds to the Walsh and Rosen
“Type III” self-mutilation. Stereotypic SIB is found mostly in mentally retarded and
autistic populations and is characterized by “monotonous repetition and a rhythmic
pattern” of self-injury (Favazza, 1996, p.237).
In this research, we are most interested in the “Type III” or “moderate/superficial
pathological” self-mutilation because it occurs most frequently in the general population
and is a troublesome and tenaciously unremitting symptom of numerous psychological
disorders. Thus, this research considers SIB to be any behavior of low to moderate
lethality that is considered socially unacceptable (i.e. not including tattoos and piercings)
and that is performed in order to relieve increasing, intolerable psychological pain.
Self-Injurious Behavior and Corresponding Diagnoses
SIB has often been studied within inpatient and incarcerated populations, due to
the fact that these subjects are easily accessible and because the amount and the severity
of the self-injury is easily monitored in these groups. As a result of this sampling bias,
self-injurious behavior has been recognized primarily as a symptom of Borderline
Personality Disorder (BPD) or as a severe symptom of Post-Traumatic Stress Disorder
(PTSD). Nonetheless, as information about this behavior has expanded, it has also been
shown to be a symptom of other Axis I and Axis II disorders (Garrison, Addy,
McKeown, Cufife, & et al., 1993; Ghaziuddin, Tsai, Naylor, & Ghaziuddin, 1992;
Herpertz, 1995; Winchel & Stanley, 1991; Zlotnik, Mattia, & Zimmerman. 1999). In a
study by Herpertz (1995), looking at the diagnostic breakdown of 54 female
psychiatric
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inpatients, the diagnoses most likely associated with SIB were eating disorders (54%)
(primarily Bulimia Nervosa (19%)), Psychoactive Substance and Alcohol Use Disorders
(33%), and Affective Disorders (20%). In terms of Personality Disorders, Herpertz
(1995) found that of 54 psychiatric inpatients with SIB, more than half were likely to he
diagnosed with BPD (52%) and almost a quarter were diagnosed with Histrionic
Personality Disorder (23%).
Garrison et al (1993) published a study examining the prevalence and correlates
of SIB in a non-patient population of adolescents (aged 12-14). They found that SIB was
most commonly associated with a concurrent diagnosis of Major Depressive Disorder
(MDD). Simeon, Stanley, Frances and Mann (1992) and Ghaziuddin et al. (1992)
similarly found that the two most common diagnoses in inpatient adult and adolescent
(respectively) self-injurers were MDD and BPD.
In the general population, the incidence of SIB has been estimated to be anywhere
from .75% (Favazza & Conterio, 1989) to 2.5% (Garrison et al., 1993) to 4% (Briere &
Gil, 1998). Even more shocking, in the college population, authors have found the
incidence of SIB to be 12% (Favazza, DeRosear, & Conterio, 1989) and 16% (Rulf
Fountain, 2001).
Description and Function of Self-Injury
As was described above, self-injury can occur as a symptom of many different
psychological disorders, and similarly, self-injury may happen as the result of many types
of external (or internal) stressors. Literature on the reasons for and functions of self-
injury is extensive. While often thought of, by the layperson, as a form of manipulation
and attention seeking, current research has demonstrated that the underlying
stressors
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leading to a particular act ol SIB arc often related to interpersonal conflict or the threat of
interpersonal loss or abandonment. To an individual who is especially sensitive to
interpersonal conflict, a stressor of this type can result in rapidly rising negative affect.
which is then exacerbated by inadequate coping skills, potentially leading to an act of
self-injury (Briere & Gil, 1998; Collins, 1996; Darche, 1990; Kemperman, Russ, &
Shearin, 1997; Pao, 1969; Raine, 1982; Suyemoto, 1998).
Self-mutilation may be used to express emotion and conflict both to
the self and to others, as well as to achieve a sense of control over
emotion that threatens to generally overwhelm the individual, her
sense of self, and her connectedness to the world.
(Suyemoto, 1998, p. 542)
Regardless of the psychological syndrome or the initial stressor, the affective
experience leading up to an act of self-injury can be remarkably similar across diagnostic
category and in the general population. Herpertz, (1995) provides a concise description
of the typical affective experience of an individual who self-injures. Prior to an act of
self-injury, individuals report experiencing internal agitation, anxiety, rage, or despair.
As the tension increases, the individual may begin to feel a sense of emptiness and
isolation followed by an inability to verbalize or to tolerate the extreme feelings. The act
of self-injury is often an impulsive act and has the effect of releasing the tension quickly .
With repeated use, SIB can become a coping mechanism for dealing with many levels of
interpersonal stressors, and unfortunately it works quite effectively both physiologically
(Brain, Haines, & Williams, 1998; Haines, Williams, Brain, & Wilson, 1995) and
psychologically (Favazza, 1996; Herpertz, 1995; Simeon, Stanley, Frances, Mann. & et
al.. 1992; Suyemoto, 1998; Turp, 1999; Walsh & Rosen, 1988) to temporarily reduce
seemingly unbearable distress.
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While it is heartening that wc arc beginning to have a comprehensive
understanding of the etiology, functions, and results of self-injurious behavior, we still
have a veiy limited understanding ol how or why this form of coping actually works.
Current researchers have very little understanding of whether there is some form of
dysregulation within a self-injuring individual's stress response system that might
differentiate them from similarly distressed individuals who do not engage in self-injury.
To explore this possibility, we must first understand how the physiological stress
management system can be dysregulated in individuals with other forms of
psychopathology.
Healthy Stress Reactivity
While a comprehensive review of the human body's response to stress is beyond
the scope of this paper, an understanding of how the hypothalamus-pituitary-adrenal
(HPA) axis system, and cortisol levels in particular, react to stressful events is imperative.
The HPA-axis functions primarily to help an individual mobilize energy to deal with
external stressors (van der Kolk, McFarlane, & Wcisaeth. 1996). Cortisol is one ol the
major hormonal products created and utilized by the HPA system and is recognized as an
indicator of HPA-axis functioning (Stansbury & Gunnar, 1994).
With the onset of an actual or perceived stressor, the human brain begins secreting
hormones in order to facilitate physiological arousal, alertness, vigilance, and appropriate
aggression (Chrousos & Gold, 1992). The hormonal stress response begins in the
hypothalamus, which releases corticotropin-releasing-hormone (CRH), which itselt acts
upon the cells of the anterior pituitary gland. The anterior pituitary begins secreting
adrenocorticotrophic hormone (ACTH), stimulating cells in the cortex and the adrenal
6
glands to produce and release cortisol into the general circulation (Stansbury & (iunnar.
1994).
Following the perception of a stressor, the HPA-axis initiates the above process in
a matter of milliseconds, nonetheless it can take anywhere from 10-15 minutes to produce
a measurable rise in circulating cortisol levels, and from 20-30 minutes to reach its peak
concentration (Stansbury & Gunnar, 1994).
Dysregulation of the HPA-axis and Psychiatric Disorders: PTSD
There are several prominent researchers in the field of HPA-axis functioning who
have begun exploring stress reactivity in people with Post Traumatic Stress Disorder
(PTSD). The work of Blanchard, Kolb, Pallmeyer, and Gerardi (1982), Blanchard, Kolb,
Gerardi, and Ryan (1986), and Pitman, Orr, Forgue, de Jong, and Claiborn (1987) began
the exploration of physiological responsivity of post-war veterans diagnosed with PTSD.
They demonstrated that PTSD patients were physiologically much more responsive
(increased heart rate, skin conductance, and EiKG) than control subjects in response to an
imagined combat script (Blanchard, Kolb, Gerardi, Ryan, & et al., 1986; Blanchard,
Kolb, Pallmeyer, & Gerardi, 1982; Pitman, Orr, Forgue, de Jong, & et al., 1987).
Interestingly, Pitman et al (1987) also found that the PTSD subject’s physiological
responses (measured as a change score from basal levels) to the neutral, non-stressful
script were smaller than the responses of control subjects. This highlighted the point that
these PTSD subjects were not simply more responsive to all stressors , but were highly
reactive to specific stimuli.
Taking this work a bit farther, Yehuda, Southwick, Nussbaum, and Wahby (1990)
and Yehuda, Resnick, Kahana, and Giller (1993) published consolidating and clarifying
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studies on HPA-axis functioning in PTSD patients. They found that PTSD patients
showed lower mean 24-hour urinary cortisol excretion (1990) and that they similarly
were shown to have more effective HPA feedback inhibition (1993). For example,
subjects who had undergone repeated traumas, such as multiple rapes, were found to have
faster cortisol recovery (as measured by return to basal score), than those who were
experiencing their first traumatic incident (Yehuda, leicher, Trestman, Tevengood, &
Siever, 1996). This seems to indicate that PTSD patients have a highly reactive (they
will respond strongly to novel stressors), yet more sensitive (the HPA negative feedback
system goes quickly into action) HPA axes than normal control subjects. Van der Kolk
(1996) explains this by stating that people with PTSD have adapted to chronic extreme
stress by hyper-tuning the stress response system, leading to decreased overall resting
levels of cortisol in the body, as well as a decreased level of cortisol secretion in response
to subsequent stressors that resemble the original stressor.
Interestingly, Yehuda, Southwick, Nussbaum and Wahby (1990) have also shown
that in response to a novel or an extreme stressor, subjects with PTSD may show a
normal or slightly increased stress response (compared to non-psychiatric participants).
But because of the HPA-axis hypersensitivity, their bodies will return to its physiological
resting state more quickly (Yehuda, Boisoneau, Mason, & Giller, 1993; Yehuda, Resnick,
Kahana, & Giller, 1993; Yehuda, Southwick, Nussbaum, Wahby, & et al., 1990).
Dvsregulation of the HPA-axis and Psychiatric Disorders: MDD
In comparison to individuals with PTSD as well as healthy controls, depiessed
patients have been shown to have a quite different pattern of HPA reactivity. Stokes and
Sikes (1987) and Gold, Goodwin, and Chrousos (1988) showed that patients with
MDD
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tend to have higher plasma and urinary levels of cortisol than non-depressed individuals.
Expanding this finding, Yehuda, Teicher, Trestman, Levengood and Sicver (1996)
monitored cortisol levels in both PTSD and MDD patients over a 24-hour period. This
research group found that while the MDD patients did not tend to have higher levels of
cortisol secretion throughout the day, they showed a significantly more dysregulated and
chaotic pattern of secretion than either the PTSD patients or the non-disordered patients.
This does not discredit the previous findings of hypercortisolism in MDD patients, but
instead helps to explain the finding, as previously hypercortisolism could only be
documented in 50% of the MDD cases studied (Gold, Goodwin, & Chrousos, 1988;
Stokes & Sikes, 1987). These patients, according to Yehuda’s findings, tend to have
increased cortisol secretion under stress, and then have a more difficult time returning to
baseline following a stressor, periodically leading to an overall higher level of cortisol
throughout the body over the course of a day.
Physiological Reactivity in Self-Injurious Behavior
Because the models of HPA-axis reactivity in MDD and PTSD patients are quite
different, it is difficult to predict the HPA-axis functioning of people who engage in SIB.
We are left to wonder whether the stress response system of people who engage in (or
who have engaged in) self-injury is functioning differently than or similarly to the PTSD
patient, the MDD patient, or the non-disordered subject.
Previous research looking at cortisol reactivity in self-injurers has been
inconclusive (Rulf Fountain, 2001) finding no differences in the baseline levels of
cortisol between self-injurers and control participants. Similarly, Rulf Fountain (2001)
found no reactivity differences between self-injurers and control subjects when
subjected
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to a mathematical and public speaking stressor. Nonetheless, for individuals who self-
injure, specific stressors may be more taxing than others, leading us to question whether
an interpersonal stressor might create more of a stress reaction for these participants.
The literature suggests that self-injury is often a coping method for dealing with
interpersonal stress. Poor communication skills, lack of connection to others, and
ambivalence about becoming attached to another person are characteristics that have been
associated with self-injurious behavior (Bennun, 1984; Collins, 1996; Favazza &
C onterio, 1989; Suyemoto, 1998; Tulloch, Blizzard, & Pinkus, 1997). These personality
and skill deficits often lead to difficulties in interpersonal relationships as well increased
distress within interpersonal conflicts (Collins, 1996; Kemperman et al., 1997; Tulloch et
al., 1997). The current study uses a pre-existing, ongoing conflict with each individual's
romantic partner as the source of stress, rather than the circumscribed, non-interpersonal
task that Rulf Fountain (2001) used, with the hopes that this type of task will be more
likely to produce significant IIPA-axis activity.
The Present Study
Because people who engage in SIB feel the impulse to cause their body physical
trauma, it seems likely that their physiological processing of stress and trauma may be
different than those who handle stress in a more adaptive way. Complicating the matter
is the fact that self-injury is not considered a disorder, but rather a feature of numerous
psychological disorders such as Post Iraumatic Stress Disorder, and Major Depressive
Disorder. As described above, these disorders have both been shown to have different
stress reactivity profiles. The current study explores how people who engage in SIB
experience stress, with the ultimate goal of understanding how symptoms of P FSD and
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MDD may contribute to SIB patterns of stress reactivity. Thus, this study is driven by
five main research inquiries.
Questions
1 ) How is SIB related to current trauma or depressive symptoms?
2) Is the current interpersonal stressor creating an HPA-axis response measurable by
salivary cortisol?
3) Is there a relation between the basal cortisol score, anticipatory score, reactivity,
time of peak, and extent of recovery of stress-induced cortisol reactivity and SIB?
4) Does the relation between SIB and HPA-axis reactivity change when taking into
consideration depressive symptoms, trauma symptoms?
5) Do depression and trauma symptoms moderate the relation between SIB and
HPA-axis reactivity?
11
CHAPTER 2
METHOD
Participants
Participants for the study are 1 70 older adolescents (aged 1 8-21 ) who are part of a
larger study exploring a biopsychosocial model of adolescent depression. The larger
study is conducted in three sessions taking place over the course of six months. All
information in the current study was collected during the first session. Recruitment for
the study was completed in the five-college community of the Pioneer Valley as well as
surrounding non-college community members. Late adolescence was chosen as the
developmental period in this project for three reasons: a) current research on SIB has
shown high levels of self-injurious behavior among college-aged adolescents (Alexander,
1999; Rulf Fountain, 2001); b) HPA reactivity and behavioral coping has focused on
infancy through middle adolescence and has not examined late adolescence; c) and
finally, because this is a time period during which romantic relationships are of increased
importance, the use of an interpersonal stressor will likely be quite effective in creating a
physiological response (Kirschbaum & Hellhammer, 1989).
The final sample for this project consisted of 85 (50%) males and 85 (50%)
females. Ages ranged from 18 to 21 years old with a mean age of 19.3 years old
(SD=0.87). The sample came from a fairly well distributed range of socioeconomic class
backgrounds, as measured by parental education levels. Forty (23.5%) mothers have
completed a graduate degree, 6 (3.5%) have completed some graduate school, 49 (28.8 /o)
have completed a college degree, 32 (18.8%) have completed some college, and
42
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(24.7%) completed either high school or some form of trade school. Fifty-two (30.6%)
fathers have completed a graduate degree, 3 (1.8%) have completed some graduate
school, 53 (31.2%) have completed a college degree, 24 (14.1%) have completed some
college, and 34 (20.0%) completed either high school or some form of trade school.
In order to compare the ethnic make-up of our sample to current census data, we
obtained statistics from the Massachusetts Institute for Social and Economic Research
regarding the demographics for youth in our community. From these statistics, we were
able to document a profile of youth in this community in the target ages. This population
is 6.1% Asian-American or Native American, 3.3% African-American, 3.9% Latino or
Hispanic, and 86.7% European-American. The community population is highly similar
to our participants, although our participants have a slightly higher proportion of ethnic
minorities. In the current sample, 9 (5.3%) individuals report Asian or Asian-American
heritage, 1 (0.6%) is Native American, 2 (1.2%) are African-American, 12 (7.1%) are
Latino or Hispanic, and 137 (80.6%) are of European-American decent. Eight (4.7%)
participants claim “Other' racial background and 1 participant failed to report his ethnic
background.
Recruitment
Recruitment for the current study was done through posters, sign-up sheets via
psychology classes, and word ot mouth. Participants in the current study are recruited
based on three primary factors: 1) they are between the ages ol 18 and 21; 2) they are
currently in romantic relationships which have been ongoing for at least 2 months; 3) and
their partners must also be between the ages of 18 and 21. Individuals in both same sex
and opposite sex romantic relationships are welcome to participate.
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No over-sampling oi individuals who have engaged in self-injury was necessary
in order to boost the SIB sample. Initial data analysis and previous studies using this
population have shown that the prevalence of SIB is quite high, which was confirmed by
our exclusive use of subjects recruited only on the basis of their age and relationship
status.
Each participant was paid $20 for their participation in the initial 3-hour session.
$20 for the 2 session and $40 for the 3 rti session. Additionally, participants who were in
introductory psychology classes at the University of Massachusetts had the option to
receive six psychology research credits toward their final grade in the course.
Procedure
During an initial telephone-screening interview, participants are informed that
they are invited into the lab with their romantic partners to participate in a study about
conflict negotiation between romantic partners and about individuals' physiological
reactions when involved in discussions with their partners. They are additionally told to
refrain from drinking alcohol, using illegal drugs, or visiting the dentist within the 24
hours prior to the study. They are asked not to exercise, eat, drink (except water), smoke
cigarettes, or brush their teeth up to 2 hours prior to the study because any contaminants
in their saliva may alter the accuracy of the cortisol measurements.
When adolescents arrive at the laboratory they are welcomed and given a review
of the purpose and procedures of the project. I hey are told that the purpose of the study
is to learn more about how romantic partners communicate with each othei and about
individuals’ physiological reactions when involved in discussions with theii partneis.
Participants are seated in one room at individual tables with computers, separated
by a
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cloth room divider. The divider ensures that participants cannot see each other's
responses to computerized questionnaires and discourages talking about answers.
Participants are given the informed consent form to read and sign (Appendix A).
Eacn participant is then given a thermometer with removable sanitary cap that assesses
temperature by placement under the tongue. Participants’ temperatures are assessed to
ensure that participants are not acutely ill, as this may afTect HPA functioning. If
participants have an elevated temperature or feel ill; report that they have had alcohol,
used illegal drugs or had any mouth or gum abrasion in the past 24 hours; or report that
they have brushed their teeth, eaten, drunk caffeinated beverages or exercised in the past
two hours, they are scheduled to return at a later date.
Next, participants fill out an Admission Questionnaire (Appendix B) that contains
information about variables that potentially affect HPA functioning, such as the number
of hours of sleep the previous night, daily medications or vitamins, the use of oral
contraceptives, phase of menstrual cycle, and the possibility of pregnancy, as these topics
may be subject to statistical control at the time of data analysis. When the admissions
form is completed, participants give the first salivary cortisol sample (a baseline sample).
Couples are then given a detailed description of the conflict task and fill out a form that
asks them each to name a recent source of disagreement. Participants separately choose a
conflict topic with the understanding that they will be asked to discuss one of the topics
during the conflict task. Ten minutes following the detailed description of the task,
participants give a second salivary cortisol sample that serves as a pre-task measure of
anticipatory anxiety. Anticipatory anxiety will be measured in order to differentiate
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between physiological reactivity to the imagined interaction, and reactivity that is more
likely to be associated with the conflict task.
Meanwhile, a research assistant chooses one of the issues (using a coin toss) that
will serve as the topic of discussion and writes it on an index card. The couple is then
brought to another room in the laboratory equipped with three wall-mounted digital video
cameras and a couch. The couple is asked to sit on the couch and the cameras are turned
on. The note card is placed on the floor in front of the couple and the research assistant
says, “On this card is an issue which has come up between the two of you in the past. I
have tossed a coin and chosen one of the topics that one of you stated has been a source
of disagreement. We would like you to spend 15 minutes discussing this issue. We are
interested in how couples normally discuss their differences, although we want you to
know that we recognize that being videotaped is different than being at home in private.
Please discuss this issue presenting your point of view, and try to come to a resolution of
the issue. The goal of this task is to attempt to resolve the conflict. We will end the
discussion in 1 5 minutes by knocking on the door. While you have this discussion, I will
be in the next room and will be unable to hear your discussion. Do you have any
questions before we begin?”
After completion of the conflict negotiation task, couples are taken back to the
first room and seated again at their tables, separated by the room divider, to fill out a
questionnaire packet. Participants provide five additional saliva samples during the time
that they complete the questionnaire packet. Saliva samples are collected at 10, 20, 30,
45, and 60 minutes post-task.
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There is no deception involved in this study. Individuals are informed at the end
of the 3 rd session that the primary focus of the study is an exploration of a biopsycho-
social model of adolescent romantic relationship conflict negotiation (Appendix C).
Saliva Collection Procedures and Considerations
Because cortisol levels follow a circadian rhythm, participants arc invited into the
lab at 4pm, the time period in the day during which cortisol levels are the most stable
(Kirschbaum & Hellhammer, 1989). Keeping daily cortisol levels as stable as possible
decreases the amount of noise in our cortisol data, and additionally increases the
possibility that any shifts in cortisol due to the interpersonal stressor will appear in the
data.
Saliva is collected from each participant seven times throughout the session,
following the procedures set forth by Salimetrics, LLC. the lab that we have contracted to
analyze and calculate all cortisol levels. Following their advice, participants are
instructed to use a “passive drool method” to collect the saliva samples. Grocery store
variety plastic straws are cut into three or four sections. Participants are handed a section
of a straw as well as a small plastic vial (also of the sort recommended by Salimetrics).
The participants are instructed to “passively drool down the straw and into the vial with
their heads tilted forward until the required amount of saliva is collected. The vial is then
tightly sealed and immediately placed in frozen storage (-20 degrees C) until it is shipped
to Salimetrics (on dry ice) for analysis of cortisol levels. This collection procedure is
explained to the participants and repeated at each separate saliva collection time point.
Salimetrics, FTC’s specific laboratory procedures for determining cortisol levels
can be found in Appendix D.
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Measures
Informed Consent
A consent form providing a thorough explanation of the study procedures as well
disclosure of any risks or benefits of participating in the study is provided to each
participant. An explanation of anonymity, confidentiality, and the withdrawal procedure
is explained on this form. Participants are made aware that all information is kept
confidential except in the case of disclosure of suicidal intent, homicidal intent, or child
or elder abuse. Additionally, participants are informed that they are free to withdraw at
any time point without penalty. (Appendix A)
Physical Health Questionnaire
Participants are asked about current health status, daily medications, and recent
use of illegal drugs or alcohol, recent food intake, exercise, tooth brushing, dental work,
and the number of hours slept in the past 24 hours. Female participants are asked about
their use of oral contraceptives, pregnancy, and date of last menstruation. (Appendix B)
Demographics
Demographic questions include information about the participant's age, race,
gender, and socio-economic status. (Appendix E)
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Center for Epidemiological Studies Depression Scale (CES-D)
The CES-D (RadlolT, 1977) is a 20-item questionnaire that measures depression
symptoms in community samples of adults. Similarly, the scale has been used to reliably
assess adolescent depressive symptoms (alpha > 0.87) (RadlolT, 1991; Roberts, Andrews,
Lewinsohn, & Hops, 1990). The scale is scored as a sum of the frequency of occurrence
of 20 symptoms. In the present sample of late adolescents, Chronbach’s alpha proved to
be similarly reliable (n=170, alpha = 0.82). (Appendix F)
Trauma Symptom Checklist (TSC-40)
The TSC-40 (Briere & Runtz, 1989) is a 40-item, self-report measure that
assesses the prevalence of symptoms that are likely to have arisen from adult or
childhood trauma experiences. The checklist consists of 6 subscales including: Anxiety,
Depression, Dissociation, Sexual Abuse Trauma Index, Sexual Problems and Sleep
Disturbance. A total scale score can be calculated and has been found to be more reliable
than any of the subscales (alpha between .89 and .91) (Briere & Runtz, 1989). Only the
total scale score will be used in the current study. In the present sample of late
adolescents, Chronbach’s alpha for the total scale score proved to be similarly reliable
(n=l 70, alpha = 0.86). (Appendix G)
In the current study, the TSC-40 and the CES-D are highly correlated (r( 1 70)
=
0.48, p<0.001), although their overlap accounts for only 25% of the variance in scores.
We have therefore decided that the scales are measuring different phenomena.
Self-Injurious Behavior Questionnaire (SIB-Q)
A measure assessing the occurrence of self-injurious behavior was constructed for
this study from self-injury literature and from several pre-existing
measures (Alexander.
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1999; Rulf Fountain, 2001). The questionnaire asks the participant about any instances
of self-inflicted injury that would fall into the “Type III” category of SIR. Participants
are asked how many times they have engaged in each of 9 behaviors including: ever self-
harmful, self-bruising, self-hitting, hair-pulling, self-scratching, self-biting, self-
poisoning, self-burning, and self-cutting. The questionnaire also assesses the recency of
each type of self-injurious behavior that the participant acknowledges having used. The
exact wording assessing each behavior can be found in Appendix H.
Self-injury scores were calculated in four ways. Initially, following the
methodology of Rulf-Fountain (2001) a weighted-continuous measure of SIB, titled
“SIB-weighted” was calculated in a manner that took into consideration the severity of
the form of the behavior as well as the frequency and the recency of the act. The
methodology for calculating the “SIB-weighted” score follows. Mild self-mutilative
behavior (including “ever harmful,” “self-bruising,” “self-hitting,” and "hair-pulling' )
was given a weighted score of 1 . Moderately damaging self-mutilative behavior
(including “self-scratch” and “self-bite”) was given a weighted score of 5. The more
severe forms of self-injury (including “self-poison”, “self-burn'’, and “self-cut ’) were
given a weighted score of 10. Next, the sum of the occurrence of each weighted behavior
was multiplied by the frequency (which is a score between zero and five). For example,
if a participant reported having cut herself “between 6-10 times” (severity of 10 and
frequency of 3) and having bitten herself “between 2-5 times” (severity
of 5 and
frequency of 2), the weighted score would be (3*10) + (2*5)
= 40 (i.e.
frequency i * severity i + frequency2 *severity2 + frequency3
severity3...).
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The final step in calculating the “SIB-weighted” score is to take the recency of the
behavior into account. The scores calculated above were multiplied by either 1 or by 10.
Scores of the participants who had engaged in the behavior within the past 6 months,
were multiplied by 10. While scores of those who had not engaged in the behavior
within the past 6 months, were multiplied by 1 . So, continuing with the above example,
if the participant reported that she had last engaged in one of the behaviors within the past
month, her “SIB-weighted” score would be calculated as: 10 f(3* 10) + (2*5)] = 400.
Additionally, 3 more stringent and specific measures of SIB were calculated. The
first, titled “SIB-severity”, is a score indicating whether a participant has engaged in any
of the more severe forms of self-injury (self-scratching, self-biting, self-poisoning, self-
burning, or self-cutting) two or more times, at any point in their lives. The second self-
injury scale, titled “SIB-frequency”, is a continuous measure of the maximum frequency
of any form of severe self-injury. The score ranges from 0 to 5, with a score of 0
representing never having engaged in any of the severe forms of self-injury. A score of 1
represents only a single occurrence of any of the forms of severe self-injury. A score of 2
indicates that the individual engaged in at least one of the forms of behaviors between 2-5
times. A score of 3 represents 6-10 times. Four represents 1 1-20 times and a score of 5
represents engaging in at least one of the behaviors over 20 times.
The final measure of self-injurious behavior, titled “SIB-recency" takes into
account only the recency of the self-injury; but once again is only assessing the more
severe forms of self-injury (self-scratching, self-biting, self-poisoning, self-burning, or
self-cutting). This score is a continuous measure of the how recently the individual
engaged in any of the more severe forms of self-injury. The score ranges from 0 to 6,
21
with a score of 0 representing never having engaged in any of the severe forms of self-
injury. A score of 1 represents having engaged in the behavior over 5 years ago. A score
of 2 indicates that the individual engaged in at least one of the forms of behaviors
between 1 to 5 years ago. A score of 3 represents the fact that the behavior occurred
within the past year. Four represents the past 6 months; a score of 5 represents engaging
in at least one of the behaviors in the past month, and 6 indicates that it occurred within
the past week.
Cortisol Measurements
Cortisol levels and reactivity were evaluated using 10 different variables. The
first seven variables are simply the level of salivary cortisol measured lor each individual
at each of the seven time points. The first measurement is considered the basal level, the
second is the anticipatory level, and as mentioned above, the third through seventh
measurements represent reactivity to the assigned task at 10, 20, 30, 45, and 60 minutes
post task. The final three cortisol variables are calculations which represent the cortisol
profile of each individual. The first variable is a measure of HPA-axis reactivity, as
represented by the basal cortisol level subtracted from the maximum cortisol level. In
accordance with numerous researchers (Granger, Stansbury, & Henker, 1994; Yehuda.
Resnick et al.. 1993) this is often chosen as a marker of HPA-axis functioning, with
higher scores indicating increased stress reactivity in response to a stressor. I he second
variable represents how quickly each individual reached their maximum coitisol le\el
and is simply the time point in minutes at which that occurred. Following (Yehuda.
Boisoneau et al., 1993; Yehuda, Resnick et al., 1993; Yehuda et al., 1990) findings
that
individuals with PTSD show more “fine-tuned” HPA-axis responses to stress,
this
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variable will allow us to measure how quickly participants’ IIPA-axes respond to the
anticipation of or the actual occurrence of the interpersonal stressor. The final cortisol
measurement is a calculation ol the extent of cortisol recovery at the end of the study,
represented by the final cortisol level subtracted from the basal score. Again, based on
previous literature which suggests a difference in the ability of traumatized individuals
and depressed to return to their basal cortisol levels (Yehuda et al., 1996) this variable
will allow us to assess the relations between the extent of recovery and our measures of
psychopathology.
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CHAPTER 3
RESULTS
Results are presented in 6 sections that directly follow the research questions. All
data was analyzed separately for men and women due to the fact that their data is not
independent.
Preliminary Analyses
Means, standard deviations and frequencies of cortisol levels, trauma symptoms
(TSC-40), depressive symptoms (CES-D), and self-injury scores are shown in Tables 1
and 2. Statistically significant sex differences in the psychopathology variables were
found only for trauma symptomatology. Women in our sample had higher levels of
trauma symptoms than men. No gender differences were found in levels of depressive
symptoms or in any of the measures of self-injury (see Table 1).
Among the cortisol variables, men had higher levels of salivary cortisol at the 2 nd
collection time, which represents the anticipatory measurement point in the paradigm.
There were no sex differences in any of the other six collection points. Interestingly,
while there were no sex differences in cortisol reactivity or in the time-to-peak variable,
men showed significantly more recovery in their reactivity than did the women (see
Table 2). Tables 3 and 4 show the frequencies of the recentness and of the types of self-
injurious behavior for men and women.
Question 1 : How is SIB related to current trauma or depressive symptoms?
In order to assess the ways in which SIB is related to current trauma or depressive
symptoms, correlations of the CES-D, the TSC-40, and the SIB variables
were
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completed. None of the self-injury variables correlated significantly with depression or
trauma symptoms for the men, but there were many significant correlations for the
women (see fable 5). Each of the four women's self-injury variables is correlated with
trauma symptoms in the expected direction. Only the SIB-weighted score fails to be
significantly correlated with depressive symptoms, while each of the three variables
looking at more severe self-injury (SIB-ffequency, SIB recency, and SIB severity) is
significantly correlated with depressive symptoms.
Question 2: Is our stressor creating a measurable HPA-axis response?
In order to assess whether our stressor is creating a measurable HPA-axis response,
paired T-tests were used to compare the maximum level of cortisol with the basal cortisol
levels. Cortisol levels for both men and women were significantly higher at their
maximum level than at their basal level (see Table 6). A graph of the mean cortisol
profiles for both men and women demonstrates this elevation and subsequent decline
(See Figure 1).
Question 3: Is there a relation between SIB and Cortisol Variables?
All regressions include variables controlling for alcohol use within the past 24
hours, use of Selective Serotonin Reuptake Inhibitors (SSRIs), as well as use of allergy
medications as each of these were significantly correlated with several cortisol levels and
cortisol reactivity. No other daily medications or physiological variables were
significantly correlated with cortisol levels at any time point used in further analysis or
with the profile variables (See Tables 7 & 8). Only men reported using alcohol in the 24
hours before the study (N=6), and only women reported using SSRIs (N=l), hence
these
variables were only included in the appropriate sex-specific regression
equations.
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Multiple regression analyses were used to examine whether self-injurious
behavior is related to HPA-axis activity in response to the interpersonal stressor and are
represented by the following equations:
1) 10 Cortisol variables W Allergy meds (AM) + Alcohol (Ale) + SSRIs + SIB (weighted)
2) 10 Cortisol variables W AM + Ale + SSRIs + SIB (severity)
3) 10 Cortisol variables W AM + Ale + SSRIs + SIB (frequency)
4) 1 0 Cortisol variables W AM + Ale + SSRIs + SIB (recency)
The SIB recency variable for women predicted the time at which the participant
reached her peak cortisol level. As expected, for women, the more recently they had
engaged in self-injury, the more quickly they reached their peak cortisol reaction to
interpersonal conflict (see Table 9). No other direct relations were found between self-
injury and cortisol levels in either men or women.
Question 4: Does the relation between SIB and HPA-axis reactivity change when taking
into consideration depressive symptoms, trauma symptoms?
In order to assess the importance of depression and trauma symptoms to the
cortisol profile, and to assess whether these variables would better account for the
previous finding, the following simultaneous multiple regressions were performed.
1) 10 Cortisol variables W AM + Ale + SSRIs + SIB (weighted) + CES-D + TSC-40
2) 10 Cortisol variables W AM + Ale + SSRIs + SIB (severity) + CES-D + TSC-40
3) 10 Cortisol variables W AM + Ale + SSRIs + SIB (frequency) + CES-D + TSC-40
4) 10 Cortisol variables W AM + Ale + SSRIs + SIB (recency) + CES-D + TSC-40
Controlling for current depressive and trauma symptoms weakened the relation between
SIB recency and the time of peak cortisol levels, leaving only a trend toward significance
(See Table 10). No further significant relations were found while exploring these
equations.
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Question 5; Do depression and trauma symptoms moderate the relation between SIB and
HPA-axis reactivity?
1 he following simultaneous multiple regressions were performed in order to
assess whether trauma symptoms or depression symptoms play a moderating role in the
relation between self-injurious behavior and HPA-axis functioning. Variables in
interaction terms were centered to reduce multicolinearity.
1) 10 Cortisol variables WAM + Ale + SSRls + SIB weighted + CES-D + CES-D*SIB
weighted
2) 10 Cortisol variables W AM + Ale + SSRls + SIB severity^ CES-D + CES-D*SIB severity
3) 10 Cortisol variables W AM + Ale + SSRls + SIB frequency + CES-D + CES-D*S1B
frequency
4) 10 Cortisol variables W AM + Ale + SSRls + SIB recency + CES-D + CES-D*SIB recency
5) 10 Cortisol variables W AM + Ale + SSRls + SIB weighted + TSC-40 + TSC-40*SIB
weighted
6) 10 Cortisol variables W AM + Ale + SSRls + SIB severity+ TSC-40 + TSC-40*SIB severity
7) 10 Cortisol variables W AM + Ale + SSRls + SIB frequency + TSC-40 + TSC-40*SIB
frequency
8) 10 Cortisol variables W AM + Ale + SSRls + SIB recency + TSC-40 + TSC-40*SIB
recency
Several interesting relations emerged exclusively for the women. In women,
trauma symptomatology was found to moderate the relation between the level ot
anticipatory cortisol and the SIB weighted score (see Table 11 and figure 2), indicating
that at higher levels of trauma symptomatology, SIB and anticipatory cortisol levels were
positively related. Similarly, trauma symptomatology was found to moderate the relation
between the amount of time to peak cortisol levels and the SIB weighted scoie (see Table
12 and Figure 3). This interaction indicates that at higher levels ot trauma
symptomatology, as women’s SIB scores increase, the amount of time to reach
peak
cortisol levels decreases.
Depressive symptoms, on the other hand, were found to moderate
the relation
between basal cortisol levels and the SIB weighted score (see Table
13 and Figure 4), as
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well as the relation between anticipatory cortisol levels and the SIB weighted score (see
Table 14 and Figure 5). These interactions both indicate that at higher levels of
depression, women's SIB scores are positively related to basal and anticipatory cortisol
levels.
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CHAPTER 4
DISCUSSION
The aim ot this study was to examine HPA-axis functioning in response to an
interpersonal stressor in a non-clinical sample of individuals with varying levels of self-
injurious behavior. Salivary cortisol levels were measured two times prior to and five
times following the interpersonal stressor in order to obtain markers of cortisol reactivity
as a marker of HPA-axis functioning. Previous research has theorized, based purely on
self-report through clinical case studies and qualitative reports, that an act of SIB is likely
to occur in response to perceived threats of interpersonal loss or abandonment (Briere &
Gil. 1998; Collins, 1996; Darche, 1990; Kemperman et al., 1997; Pao, 1969; Raine, 1982;
Suyemoto, 1998). The current study strengthens this association by demonstrating that
self-injury is related to interpersonal stress on a physiological level, and that the relation
between self-injury and interpersonal stress is different for men and women.
Additionally, the present study shows that the relation between sell-injury and
interpersonal stress reactivity is moderated by depression and trauma symptoms in ways
that are supportive ot previous literature on HPA-axis reactivity, finally, the current
study used a sample of college-aged participants from the general population,
demonstrating that this phenomenon is occurring and is measurable even in sub-clinical
populations. As a result, these findings have implications for theories ol etiology,
development, maintenance, and treatment of self-injurious behavior not just
in patient
populations, but also in the general public.
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In prior studies looking at HPA-axis reactivity to an induced stressor, clear
indications of HPA-axis reactivity have been inconsistent. Pack of reactivity has been
explained as being related to timing in the circadian rhythm of cortisol (Klimes-Dougan
et al., 2001) or to the type of stressor used (Rulf Fountain, 2001 ). By taking each of these
factors into account, through measuring salivary cortisol at a time of day when the daily
levels are thought to be most stable, and by using a personally relevant stressor, we were
able to show a clear relation between basal cortisol levels and a subsequent increase
either in anticipation of or in reaction to engaging in the induced stressor.
Additionally, the current study is ground breaking in that little research has been
done looking at physiological stress reactivity in self-injurers (Brain et al., 1998; Haines
et al., 1995), and only one unpublished study has looked at stress induced cortisol
reactivity in these individuals (Rulf Fountain, 2001). Rulf-Fountain's (2001) study
assessing cortisol reactivity and self-injurious behavior was unable to find any direct
relation between the two variables. In the current study, by assessing the recency of
severe types of self-injury, a relation was found that indicated that for women, the more
recently they had engaged in one or more severe forms of SIB, the more quickly they
react to the interpersonal stressor and reach peak levels of cortisol. These women react
physiologically to a conflict with their romantic partner quite rapidly, and sometimes in
anticipation of the task. It seems they are swiftly preparing themselves against a threat.
This coincides with literature which suggests that self-injurers often perceive
interpersonal conflict as a precursor to abandonment and intolerable pain (Briere & Gil,
1998; Collins, 1996; Darche, 1990; Kemperman et al., 1997; Pao, 1969; Raine, 1982;
Suyemoto, 1998). These women may be preparing themselves for a major threat to the
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ego which has been shown to be associated with increased cortisol response (Kirsehhaum
& Hellhammer, 1989).
Interestingly, as described above, women displayed a clear relation between self-
injurious behavior and cortisol reactivity, while men showed no relation between these
factors. This likely points to significant differences in the meanings and functions of
self-injury for men and women. It seems that women may engage in self-injury in
response to conflictual, depressive, or traumatic experiences, while men may engage in
self-injury for reasons such as machismo or displays of strength.
For example, in a separate section of the study, participants are given the
opportunity to explain the reasons behind some of their self-injurious behavior. One
young man described numerous incidents of self-injury by stating: “If someone tries to
hurt me I hit myself to show them that they can't hurt me. I only bite my arm to show
people the indent of my crooked teeth. I sometimes punch the wall during arguments.” In
contrast, a young woman describes her self-injury as occurring: “...when I feel depressed
and all pent up emotionally. Oh yes, and when I get very very hurt by someone and upset
with someone and just so built up [emotionally] that [I] need some sort of release."
While these two examples are simply single accounts of individual experiences, the
overall themes that they represent are echoed throughout numerous descriptions. As a
result, for women, it seems as though self-injury is clearly related to increased depressive
and trauma related experiences. In summary, no relation was found between SIB in men
and HPA-axis functioning indicating that men may be utilizing self-injury in different
ways and for different reasons than women, and as a result show little connection
between SIB and physiological markers of interpersonal stress.
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Although there were no basal cortisol level differences between men and women,
men showed higher cortisol levels at the anticipatory time point (Cortisol time 2). Several
studies have documented patterns of gender differences in basal cortisol levels (Klimes-
Dougan et al., 2001) and in cortisol reactivity (Kirschbaum & Hellhammer, 1989).
Consistent with the present study, Ennis, Kelly, and Lambert (2001) reported finding that
men showed a higher increase in cortisol levels from baseline to pre-test than women.
While our difference was not as substantial as that found by Ennis et al (2001), future
explorations of sex differences in anticipatory cortisol levels will be helpful toward
clarifying this relationship.
Few gender differences within the psychopathology variables were documented.
Despite previous research which points to elevations of depressive symptoms in women
in late adolescence, we were unable to find this difference. Others have similarly failed
to show this difference (Gjerde, Block, & Block, 1988) but simply explain it as an artifact
of sampling peculiarities within their sample of adolescents. Similarly, the current study
may have failed to find increased depression in women due to overall lower levels of
depressive symptoms in our sample, especially in comparison to other studies using
similar age groups. Our study is highly involved and time consuming and may, as a
result, select mostly participants who are motivated enough to commit to participate in
three sessions over the course of six months. As a result, our participants may be less
depressed than the general population of college-aged subjects.
We did find that women demonstrated significantly higher levels of trauma
symptoms than men. This corresponds with previous findings showing that women are
at
an increased risk for developing PTSD following exposure to trauma, even when the
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increased rates of sexual trauma in women are taken into consideration (Breslau, 2001;
Stein, Walker, & Forde, 2000).
In order to assess whether levels of depression or trauma symptoms may be
accounting for or clouding the relation of SIB to cortisol, each of these factors was taken
into consideration. Interestingly, despite support in the literature for direct connections
between depression and PTSD and HPA-axis functioning (Ennis, Kelly, & Lambert,
2001; Kirschbaum & Hellhammer, 1989; Stokes & Sikes, 1987; van der Kolk et al„
1996; Yehuda, Boisoneau et al., 1993; Yehuda, Resnick et al., 1993; Yehuda et al„ 1990;
Yehuda et al., 1996), these variables only slightly weakened the relation between recent
self-injurious behvaior and the time to peak cortisol activity. Surprisingly, these
variables did not better account for the connection, and they did not directly carry any
significant association with any of the other cortisol variables themselves. Although this
is contrary to much of the literature which has found a relation between clinical diagnoses
of depression and trauma and HPA-axis functioning (Ennis et al., 2001; Kirschbaum &
Hellhammer, 1989; Stokes & Sikes, 1987; van der Kolk et al., 1996; Yehuda, Boisoneau
et al., 1993; Yehuda, Resnick et al., 1993; Yehuda et al., 1990; Yehuda et al., 1996), this
result is not wholly beyond our understanding. Much research in this area has been
inconsistent in finding clear-cut relations between HPA-axis functioning and
psychopathology in patient populations, and connections have been even more difficult to
pin-point in non-patient populations (Rulf Fountain, 2001). It is possible that the low
levels of psychopathology in the current study, have made it hard to find this connection.
Nonetheless it is meaningful that although we were unable to replicate previous findings
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directly connecting depression and PTSD to HPA activity, we were able to draw a
connection between SIB and HPA activity in this sub-clinical sample.
Despite the fact that no direct relation was found between depression, trauma and
cortisol variables, both depression and trauma symptoms were shown to moderate the
relation between self-injury and anticipatory cortisol levels in women. At higher levels
of both trauma and depressive symptomatology, as self-injury scores increased,
anticipatory cortisol levels also increased, while at lower levels of psychopathology, the
relation was shown to be opposite. For example, in women with high levels of either
depressive or trauma symptoms, higher SIB scores led to increased anticipatory cortisol
levels. This finding may support the possibility, that even in women, SIB can be utilized
for very different reasons. It seems likely that women who engage in SIB but have very
low levels of psychological distress may be self-injuring for reasons quite different than
those with high psychopathology and the reasons for the behavior may be similar to the
reasons for the men. If these women are not using SIB as a way to decrease distress or
manage emotions, the relation between increased cortisol and SIB may not hold true. But
when we measure HPA activity in women who are distressed and who have higher levels
of self-injury, we see a relation between depression, trauma, and the HPA-axis that
coincides with the literature (Yehuda et al., 1996). Women with high levels of
depression or trauma symptoms are reacting quickly in response to a stressor.
Additionally for women, trauma symptoms are moderating the relation between
the time at which they reach peak cortisol levels and self-injurious behavior. This
supports findings in the trauma literature (Yehuda et al., 1996), and re-strengthens our
earlier finding between SIB recency and time to peak in women. Women who
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experience high levels of trauma symptoms reach their peak cortisol level earlier, the
more SIB in which they engage. It seems in this case, that women with SIB may react to
stressors similarly to individuals with P TSD who are experiencing a novel stressor
(Yehuda, Resnick et al., 1993). Their HPA axes react quickly and with a strong response
in order to prepare the body to handle the impending crisis.
While some literature suggests that people with trauma symptoms show lower
basal cortisol scores (Yehuda et al., 1990; Yehuda et al., 1996), this was not supported by
our study. Nonetheless our data did support a relation between basal cortisol levels, self-
injury, and depressive symptoms which is consistent with the HPA/depression literature
(Gold et al., 1988; Stokes & Sikes, 1987; Yehuda et al., 1996). In women with higher
levels of depressive symptoms, increases in basal cortisol levels are positively associated
with increases in self-injurious behavior. This supports the theory that individuals who
use SIB in conjunction with or in response to depressive symptoms may have more
difficulty regulating HPA activity, leading to higher overall cortisol levels even when
they are not in acutely stressful situations (Gold et al., 1988; Stokes & Sikes, 1987;
Yehuda et al., 1996). Another possibility is that women with high depressive symptoms
and high SIB may have shown increased basal scores because they were experiencing
this task as a stressor before they even reached the lab. For example, they may have
experienced visiting the psychology laboratory as a stressful event in and of itself.
Limitations
Several limitations to the current study are important to point out. Because we
used a non-patient, non-clinical sample, variance in levels of psychopathology
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symptomatology were limited. Similarly, levels of self-injurious behavior were much
lower than would be expected to be seen in a patient population. While this is a
limitation, it is also a strength. Because the results were robust enough to be detected in a
non-patient population, it is likely that the relations between SIB and HPA-axis reactivity
will be measurable in more severe samples as well. Our findings with this sample also
strengthen the literature base indicating that HPA-axis dysfunction is present even when
symptomatology is not at it’s most severe levels.
Differing levels of engagement in the conflict task might also be considered a
limitation of the current study. Because individuals choose their own conflict topic, and
because they are left alone without the oversight of an experimenter, some individuals
may not be fully engaging in the task. Nonetheless, random viewing of some of the
conflicts show the couples to be highly involved in the task, despite being left alone.
Additionally, avoidance of this type of task by an individual or by a couple, may actually
represent how they naturally cope with interpersonal stress in their own lives, and may
not correlate with lower HPA-axis reactivity. Future research with these data will
examine the relation of HPA-axis reactivity to individual differences in actual coping
behaviors within the conflict task.
A final limitation of the current study is the age restrictions on the sample. Due to
the age restrictions, generalizability to the population at large is difficult. As stated
previously, this age group was consciously chosen for several reasons. Current research
on SIB has shown high levels of self-injurious behavior among college-aged adolescents,
thus rendering this an extremely relevant age group in which to study the phenomenon
(Alexander, 1999; Rulf Fountain, 2001). Additionally, because this is a time period
36
during which romantic relationships are ot increased importance, the use of an
interpersonal stressor will likely be quite effective in creating a physiological response
(Kirschbaum & Hellhammer, 1989).
Future Research
Because the field of SIB and HPA-axis reactivity is so new, future research areas
are extensive so I will only mention a few here. In this study, gender differences in
physiological reactivity and SIB emerged as a meaningful and important factor. More
systematic research into the reasons for and functions of self-injury for both men and
women may clarify gender differences in HPA-axis functioning in relation to these
behaviors. Similarly, an assessment of subjects’ current and past psychological
diagnoses in addition to symptom level measurement would add to the clinical
understanding of the participants and enhance understanding of the relations found here.
Current publications are beginning to assess not only salivary and blood cortisol
levels, but are also measuring the number of glucocorticoid receptors found throughout
the body (Yehuda, Boisoneau et al., 1993). While a study of that magnitude is invasive
(involves blood samples) and difficult to complete in a non-patient population, exploring
this factor in a non-patient sample of self-injurers would add to our understanding of the
complex relationship between behavior and physiology.
Finally, replicating this study with a patient population, including participants
with current PTSD, current depression, and ongoing self-injurious behavior will increase
the strength and the importance of the current findings. Additionally, a study including a
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more severely ill sample will advance our understanding of the progression of the IIPA-
axis dysfunction in relation to the developmental course of the psychopathology.
Conclusion
In conclusion, the current study demonstrates that self-injury is related to
dysregulation of the HPA-axis in response to interpersonal stress, that the relationship
between self-injury and interpersonal stress is different for men and women, and that the
relation between self-injury and interpersonal stress reactivity in women is moderated by
depression and trauma symptoms. Importantly, the current study also demonstrates that
this phenomenon is occurring and is measurable even in sub-clinical populations. While
the implications of these results on theories of etiology, development, maintenance, and
treatment of self-injurious behavior in both clinical populations and the general public is
still unclear, understanding the physiological underpinnings and adjustments to complex
interpersonal experiences, moves the field closer to developing detailed models of the
development, maintenance, and eventually the treatment of self-injurious behavior.
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APPENDIX A
CONSENT FORM
DESCRIPTION OF STUDY: The purpose of this study is to learn more about how couples
discuss differences. All couples have issues in their relationship about which they disagree.
Discussing topics that are sources of disagreement is a normal task involved in having a romantic
relationship. We are also interested in learning more about the relations between how couples
discuss differences and each individual s history of life events and psychological problems.
The study has THREE SESSIONS, 2 sessions will take place at the UMass lab in Tobin Hall and
1 session will take place by phone. Only session 1 requires that you come to the lab with your
partner. Sessions 2 and 3 are individual sessions. You will receive a total of $80 for participation
in all three sessions. If you are a UMass undergraduate who is eligible for psychology credit, you
will receive 6 credits for the first session 1, $40 for session 2 and an additional 6 credits, and
another $40 for completion of all three sessions. If you are not a UMass undergraduate, you will
be paid $20 for session 1, $20 for session 2, and an additional $40 for completion of all three
sessions. You should participate in this study only if you can participate in ALL THREE sessions.
Session 1
:
You will be asked to answer questionnaires about your thoughts, your past
experiences, and your romantic relationship. You will also provide 7 saliva samples. The saliva
samples will be used to measure hormone levels. The saliva samples will also be tested for the
amount of blood in your saliva. You and your romantic partner will engage in a 15-minute
conflict discussion, which will be videotaped. Later, you will be asked to watch the videotape and
answer a questionnaire about your feelings and behavior during the discussion.
Session 2: WITHIN TWO WEEKS, you will participate-INDIVIDUALLY- in an interview. The
interview asks questions about your history of life events and psychological problems.
Session 3: SIX MONTHS FROM NOW, you will be contacted by phone for a phone interview
about your feelings and thoughts, and your romantic relationship(s) in the 6 months since the last
session.
RISKS AND BENEFITS: Although we do not anticipate that participation in this study will
cause any discomfort, participation requires drooling into a straw, which may be mildly
unpleasant for some people. Further, participation will involve answering questions related to
experiences of trauma, loss, and history of psychological problems, which may be upsetting to
some people. It is important for you to know that you may discontinue participation at any time
if you become uncomfortable. There is no penalty for discontinuation. If you discontinue during
a session, you will receive payment (money or credits) for that session, but not lor the following
sessions. By volunteering as a participant in this study, you will aid us in understanding how
people communicate with their romantic partners.
CONFIDENTIALITY: All of the information that you provide in this study will be anonymous
and confidential. The only exceptions to this include a life threatening emergency or reported
child abuse. Your romantic partner will not have access to any information you provide.
Only
senior staff of the research project and other professional researchers, will have access to your
conflict discussion videotape. Undergraduate staff members will not be allowed access to these
videotapes. Your consent form and name will be stored separately from your
questionnaire and
videotape. Your data will be identified by a study ID number only, and not by name.
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We encourage you to ask our staff questions at any time during your involvement. You may also
address questions to the Principal Investigator, Dr. Sally Powers, at 545-5964.
We appreciate your participation in the project, and hope that you will find the experience to he
interesting and informative.
I have read the above statement of the nature and purpose of the research project and I agree to
participate.
Sign name
Print name
Date
APPENDIX B
ADMISSIONS QUESTIONS
ID#
— DATE SEX: F M
Please answer the following questions about yourself. Please be honest. There are no
right or wrong answers. Your information will be kept completely anonymous and
confidential. Please circle ALL that apply.
A. What medications did you take today?
1. Antibiotics yes
dose (mss.)
no
2. The pill yes no
3. Aspirin ves no
4. Advil/Tylenol yes no
5. Cold medicine yes no
6. Allergy medicine yes no
7. Asthma medication yes no
8. Norpramin/Pertofrane (Desipramine) yes no
9. Adapin/Sinequan (Doxepin) yes no
10. Anafranil ( Chloripramine) yes no
12. Tofranil (Imipramine) yes no
13. Aventvl/Pamelor (Nortriptyline) yes no
14. Triptil/Vivactil (Protriptyline) ves no
15. Surmontil (Trimipramine) yes no
16. Manerix (Moclobemide) yes no
1 7. Nardil (Pheneizine) yes no
18. Parnate Tranylcypromine) ves no
19. Prozac (Fluoxetine) yes no
20. Luvox (Fluvoxamine) yes no
21 . Paxil (Paroxetine) ves no
22. Zoloft (Sertraline) yes no
23. Asendin (Amoxapine) yes no
24. Wellbutrin (Bupropion) ves no
25. Ludiomil (Maprotiline) yes no
26. Remeron (Mirtazapine) ves no
27. Serzone (Nefazodone) yes no
28 Desyrel (Trazodone) ves no
29 Effexor (Venlafaxine) yes no
30. Tegretol (Carbamazepine) yes no ,
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A. What medications did you take today?
3 1 . Depakene/Depakote/Epival
(Phenvtion. Primidone. Valproic Acid) yes
dose (mgs.)
no
32. Eskalith/Lithane/Lithobid (Lithium) yes no
33. Inapsine (Droperidol) ves no
34. Haldol (Haloperidol) yes no
35. Loxapac/Loxitane (Loxapine) ves no
36. Moban (Molindone) ves no
37. Imap (Fluspirilene) ves no
38. Orap (Pimozide! ves no
39. Laraactil/Thorazine (Chlorpromazine) ves no
40. Moditen/Permitil/Prolixin (Fluphenazine) ves no
4 1 . Serentil (Mesoridazine) ves no
42. Nozinan (Methotrimeprazine) ves no
43. Neuleptil (Percvazine) ves no
44. Trilafon (Perphenazine) ves no
45. Piportil L4 (Pipotiazine) ves no
46. Compazine/Stemetil (Prochlorperazine) ves no
47. Sparine (Promazine) ves no
48. Maieptil (Thioproperazine) ves no
49. Mellaril (Thioridazine) yes no
50. Stelazine (Trifluoperazine) ves no
5 1 . Vesprin (Triflupromazine) ves no
52. Fluanxol (Flupenthixol) ves no
53. Navane (Thiothixene) ves no
54. Clopixol (Zuclopenthixol) yes no
55. Clozaril (Clozapine) ves no
56. Zvprexa (Olanzapine) ves no
57. Risperdal (Risperidone) ves no
58. OTHER
2.
Have you been taking any of the above medication on a daily basis for the past two
weeks, but did not take today? Yes no
a. If yes, what medication?
3. Did you smoke any cigarettes today? yes
a. If yes, how long ago did you have your last cigarette? _
4. Did you brush your teeth in the last three hours? yes
5. When you brushed your teeth today did your gums bleed? yes
6. In the past 24 hours, have you had dental work? yes
no
mins.
no
no
no
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7. In the past 24 hours, have you experienced any injury to your mouth such as burning
your mouth or tongue, cutting your mouth or lip, having a sore tooth, any irritation or
blisters on your mouth or lips? yes
8. In the past 24 hours, have you drunk any alcohol? yes
9. In the past 30 minutes, have you had any dairy products? yes
9. Did you use any other drugs (marijuana, cocaine, etc.) today?
yes
10.
When did you eat or drink last? am/pm
1
1.
Did you drink alcohol or take any non-prescription drugs last night?
yes
a) If yes. please describe
no
no
no
no
no
12.
Record Temperature
13. (For women only) Use calendar to fill out DAY AND LENGTH OF LAST
PERIOD, IF CURRENTLY MARK WHEN
BEGAN
14. What time did you fall asleep last night?
1 5. What time did you wake up today?
1 6. How many hours of sleep have you gotten in the past 24 hours?
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APPENDIX C
PARTICIPANT FEEDBACK FORM
IItc purpose of this study is to leant more about social interactions between romantic
partners. Specifically, we were interested in people’s thoughts, feelings, and physiological processes
involved in conflict negotiation with their romantic partners. The answers you provided on the
computer questionnaires will help us gain a better understanding of how romantic partners negotiate
conflict, learn more about the thought processes that are activated during conflicts with romantic
partners, and better understand the life experiences related to romantic conflict. ITie saliva samples
you provided for us will help us gain a better understanding of the physiological processes that are
involved in resolving differences in close relationships.
\\ e expect that some people have stronger emotional and physiological responses to conflict
situations than others do. We believe that these responses will, in turn, influence the wavs they
communicate with their partner. It we can gain a better understanding of the processes involved in
conflicts, we will be better able to develop interventions for couples who are involved in troubled
romantic relationships.
Sometimes when people discuss their thoughts and feeling about their relationship and past
experiences, they decide they would like to further discuss these concerns with a professional
counselor. We would like to provide you with the number of three professional counseling services
at the University of Massachusetts/ Amherst. The Psychological Services Center (PSC) may be
contacted from 9-5pm, Monday-Fnday. The University Mental I lealth Sendees provides a 24-hour
sendee in which you may contact a counselor. The Everywoman’s Center provides a 24-hour
rape/violence hotline sendee in which you may contact a trained crisis counselor.
PSC (413) 545-0041
UHS Mental I lealth division (413) 545-2337
Everywoman’s Center (413) 545-0800
We would be happy to provide the results of this study to you if you are interested in
obtaining further information about this study. If you have any other questions about this study,
please feel free to contact us at (413) 545-5964.
Dr. Sally Powers, Professor of Clinical Psychology
Cheryl Boruca, Clinical Psychology Graduate Student
Plliza McArdle, Clinical Psychology Graduate Student
Anne Smith, Clinical Psychology Graduate Student
Elizabeth Seeley, Clinical Psychology Graduate Student
Meredith Gunlicks, Clinical Psychology Graduate Student
I"hank you for your time and participation. Within the week we would like you to participate
in a clinical interview about your his tor}’ of life events and psychological history. At tins
second
session, we would like you to come to the lab individually. A clinical psychology graduate student
will conduct the clinical interview. Undergraduate students will not be conducting
interviews. Hie
interview wall require two hours of your time. We wall be calling you within the week to confirm
the
date for the second session. We will also call you the day before the scheduled interview to
remind
you about the interview.
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APPENDIX D
SALIMETRICS CORTISOL ANALYSIS INFORMATION
SAllMETFll(Su<
,
HS-Cortisol High Sensitivity Salvary
Cortisol Enzyme Immunoassay Kit
For Research Use Only, Not For Diagnostic Use
Intended Use
Salimetrics HS-Cortisol kit is a competitive immunoassay specifically designed for the quantitative
measurement of salivary cortisol. It is not intended for use with serum/plasma or for diagnostic
use. It is intended only for research use with saliva. Please read the complete kit insert before
performing this assay. For further information about this kit, its application, or the procedures in
this insert, please contact the technical service team at Salimetrics by phone at (800) 790-2258,
Fax (814) 234-1608, or online at www.salimetrics.com .
Introduction
At Salimetrics, we know that the current market approach to the application of immunoassay
techniques in the measurement of biomarkers in saliva is problematic. This assay kit has been
designed to specifically address the following three problems. First, the majority of available
immunoassays for saliva cortisol are modifications of protocols developed for the use with
serum/plasma. The calibrators used in those assay kits are suspended in a human serum matrix.
Given that the composition of serum is markedly different from saliva, these calibrators are likely
to produce results that are influenced by matrix differences. To ensure the most accurate results,
this salivary immunoassay is designed using a matrix that matches saliva. Second, the level of
cortisol in saliva is significantly lower than levels in the general circulation. The use of a standard
curve developed to capture the range of values expected in serum/plasma samples is often not
sensitive enough to capture the complete range of individual differences in the level expected in
saliva. This assay is designed to capture the full range of salivary cortisol levels while using only
25 pi of saliva per test. Third, the pH of saliva is easily lowered or raised by the consumption of
food or drink. Performance of immunoassays becomes compromised as the pH of samples to be
tested drops below 4 (1). This results in artificially inflated levels. This assay system is designed
to be very sensitive to the effects of interference caused by collection techniques that affect
pH.
In addition, a built-in pH indicator warns the user of acidic or basic samples.
Test Principle
.
,
.
A microtitre plate is coated with rabbit antibodies to cortisol. Cortisol in standards and
unknowns
compete with cortisol linked to horseradish peroxidase for the antibody binding sites.
After
incubation, unbound components are washed away. Bound cortisol peroxidase is
measured by
the reaction of the peroxidase enzyme on the substrate tetramethylbenzidine
(TMB). This
reaction produces a blue color. A yellow color is formed after stopping the reaction
with 2 molar
sulfuric acid. Optical Density is read on a standard plate reader at
450 nm. The amount of cortisol
peroxidase detected is inversely proportional to the amount of cortisol
present (2).
Special Feature
A pH indicator in the assay diluent alerts the user to samples with
high or low pH values. Acidic
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samples will turn the diluent yellow. Alkaline samples will turn the diluent purple. Dark yellow or
purple wells indicate that a pH value for that sample should be obtained using pH strips Cortisol
values from samples with a pH < 3.5 or > 9.0 may be artificially inflated or lowered (1).
Precautions
1
. Stop Solution is a solution of sulfuric acid. This solution is caustic; use with care.
2. This kit may or may not use break-apart microtitre strips. Unused wells must be stored at
4°C in the sealed foil pouch and used in the frame provided.
3. Do not mix components from different lots of kits.
4. When using a multichannel pipette, reagents should be added to duplicate wells at the
same time. Follow the same sequence when adding additional reagents so that
incubation time with reagents is the same for all wells.
5. See Material Safety Data at the end of procedure.
6. As for all quantitative assays for salivary analytes, we highly recommend that samples be
screened for possible blood contamination. This can be efficiently and economically
accomplished using Salimetrics Blood Protein EIA Kit (Cat no. 1301). For a description of
this assay or an assay kit insert see www.salimetrics.com .
7. Routine calibration of pipettes is critical for the best possible assay performance.
8. Pipetting of samples and reagents must be done as quickly as possible (without
interruption) across the plate.
Storage
All components of this kit are stable at 2-8°C until the kit's expiration date.
Reagents and Reagent Preparation
1 . Anti-Cortisol Coated Plate: A ready to use microtitre plate pre-coated with antibodies in a
resealable foil pouch.
2. Cortisol Standard: Cortisol, at a concentration of 1 .8 pg/dL.
3. Wash Buffer: A 10X phosphate buffered solution containing detergents and a non-
mercury preservative. Dilute the wash buffer concentrate 10 fold with room temperature
deionized water (100 ml of 10X wash buffer to 900 ml of deionized H 20). (*lf precipitate
has formed in the concentrated wash buffer, it may be heated to 60°C for 15 minutes.
Cool to room temperature before use in assay.)
4. Assay Diluent: A phosphate buffered solution containing a pH indicator and a non-
mercury preservative.
5. Enzyme Conjugate: A solution of cortisol labeled with horseradish peroxidase.
6. Tetramethylbenzidine (TMB): A non-toxic ready to use solution.
7 Stop Solution: A solution of sulfuric acid in distilled water. (USA customers only). Stop
solution is provided in powdered form to customers outside the USA.
Reconstitute the
powdered stop solution with 12.5 mL of deionized water. Let sit for 20 minutes before
use.
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8. Non-specific Binding Wells: In order to support multiple use, four extra NSB wells are
included in kits containing break-apart plates. They are located inside the foil pouch, in
the extra strip. (NOTE: All wells in the extra strip are NSB's!)
Specimen Collection
The preferred saliva collection method (3,4) is to use plain (non-citric acid) cotton Salivettes
(Sarstedt). Freeze all saliva samples prior to assay in order to precipitate mucins. Thaw
completely, vortex, and centrifuge at 1500 x g (@3000 rpm) for 15 minutes. Pipette clear sample
into appropriate wells.
Procedure
Bring all reagents to room temperature.
Step 1: Determine your plate layout. Here is a suggested layout.
1 2 3 4 5 6 7 8 9 10 11 12
A 1 .80 Std 1 .80 Std Control H Control H
B .600 Std .600 Std Control L Control L
C .200 Std .200 Std Sample 1 Sample 1
D .067 Std .067 Std Sample 2 Sample 2
E .022 Std .022 Std Sample 3 Sample 3
F .007 Std .007 Std Sample 4 Sample 4
G Zero Zero Sample 5 Sample 5
H Nsb Nsb Sample 6 Sample 6
Step 2: If using strip plates, keep the desired number of strips in the strip holder and place the
remaining strips back in the foil pouch. Reseal the zip-lock and refrigerate the pouch at 4 C
Caution: Extra NSB wells should not be used for determination of calibrators or unknowns.
Step 3:
Label five microcentrifuge tubes or other small tubes 2 through 6.
Pipette 100 pi of assay diluent in tubes 2 through 6.
Serially dilute the standard 3X by adding 50 pi of the 1 .80 pg/dL standard
(tube 1) to tube
2. Mix well. After changing pipette tips, remove 50 mL from tube 2! to
tube 3. Mix. we
_
Continue for tubes 4, 5, and 6. The final concentrations of standards
for tubes 1 through
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6 respectively are 1 .800 pg/dL, 0.600 pg/dL, 0.200 pg/dL, 0.067 pg/dL 0 022 uq/dL and
0.007 pg/dL. HU '
• Values in nmol/L are 49.66, 16.55, 5.52, 1 .84, 0.61
,
and 0.20 nmol/L respectively.)
• Pipette 24 mLs of assay diluent into a disposable tube. Set aside for Step 5.
Step 4:
• Pipette 25 pL of standards and unknowns into appropriate wells. Standards and samples
should be assayed in duplicate.
• Pipette 25 pL of assay diluent into 2 wells to serve as the zero.
• Wells H-1
,
2 are non-specific binding wells. These wells do not contain any anti-cortisol
antibody. Pipette 25 pL of assay diluent into each of these wells to serve as the non-
specific binding.
Step 5: Make a 1 : 1,600 dilution of the conjugate, by adding 15 pL of the conjugate to the 24 mL
of assay diluent prepared in Step 3, (full plate only). Immediately mix the diluted conjugate
solution and pipette 200 pi into each well using a multichannel pipette.
Step 6: Mix plate on rotator for 5 minutes at 500 rpm (or tap to mix) and incubate at room
temperature for an additional 55 minutes.
Step 7: Wash the plate 4 times with IX wash buffer. A plate washer is recommended. However,
washing may be done by gently squirting wash buffer into each well with a squirt bottle or by
pipetting 300 pi of wash buffer into each well, and then discarding the liquid by inverting the plate
over a sink. After each wash, the plate should be thoroughly blotted on paper towels before being
turned upright. If using a plate washer, blotting is still recommended after the last wash.
Step 8: Add 200 pL of TMB solution to each well with a multichannel pipette.
Step 9: Mix on a plate rotator for 5 minutes at 500 rpm (or tap to mix) and incubate the plate in
the dark at room temperature for an additional 25 minutes.
Step 10: Add 50 pL of stop solution with a multichannel pipette.
Step 11:
• Mix on a plate rotator for 3 minutes at 500 rpm (or tap to mix). Caution: DO NOT mix at
speeds over 600 rpms. Wells are very full!
• Wash off bottom of plate with a water-moistened lint-free cloth and wipe dry.
• Read in a plate reader at 450 nm. Read plate within 10 minutes of adding stop solution
(correction at 492 to 620 is desirable).
Calculations
1 . Compute the average Optical Density (OD) for ail duplicate wells.
2. Subtract the average OD for the NSB wells from the average OD of the zero, standards,
and unknowns.
3. Calculate the percent bound (B/BO) for each standard by dividing the average OD (B) by
the average OD for the zero (BO).
4. If calculating the results by hand, plot B/BO on the vertical axis against the log of the
concentration on the horizontal axis for each calibrator and draw a straight line
through
the points. Determine the concentrations of the unknowns by interpolation.
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5. If using software capable of logistics, use a 4 parameter sigmoid minus curve fit.
Otherwise, use log-linear regression.
Typical Results
The following charts and graphs are for illustration only and SHOULD NOT be used to calculate
results from another assay.
Well Sample AverageOD B B/Bo
Cortisol
(ug/dL)
A1.A2 SI 0.229 0.205 0.1207 1.613
B1.B2 S2 0.419 0.395 0.2326 0.757
C1.C2 S3 0.737 0.713 0.4199 0.214
D1.D2 S4 1.090 1.066 0.6278 0.052
E1.E2 S5 1.330 1.306 0.7691 0.020
F1.F2 S6 1.561 1.537 0.9052 0.008
G1,G2 BO 1.722 1.698 NA
HI ,H2 NSB 0.024 NA NA
Example: Standard Curves
Log-Linear Regression
G6*.-
- 1
lor; Gf itfctrli&w
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4-Parameter Sigmoid Minus Curve Fit
ug/dL
Material Safety Data*
Hazardous Ingredients
Stop Solution is a solution of sulfuric acid. This solution is caustic; use with care. We recommend
the procedures listed below for all kit reagents.
Handling
Follow good laboratory procedures when handling kit reagents. Laboratory coats, gloves, and
safety goggles are recommended. Wipe up spills using standard absorbent materials while
wearing protective clothing. Follow local regulations for disposal.
Emergency Exposure Measures
In case of contact, immediately wash skin or flush eyes with water for 15 minutes. Remove
contaminated clothing. If inhaled, remove individual to fresh air. If individual experiences difficulty
breathing, give oxygen and call a physician.
*The above information is believed to be accurate but is not all-inclusive. This information should
only be used as a guide. Salimetrics shall not be liable for accidents or damage resulting from
contact with reagents.
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Concentrations in Frozen Versus Mailed Samples. Psychoneuroendocrinology, 23,
613-616.
4. Kirschbaum, C., Read, G.F., & Hellhammer, D.H. (1992). Assessment of Hormones
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in Saliva in Biobehavioral Research. Kirkland, WA: Hogefe & Huber Publishers.
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HS Cortisol EIA Assay Performance Characteristics
Recovery: Two saliva samples containing different levels of endogenous cortisol were spiked
with known quantities of cortisol and assayed.
Sample Endogenous
(ug/dL)
Added
(ug/dL)
Expected
(ug/dL)
Observed
(ug/dL)
Recovery
(%)
1 0.41 0.54 0.95 0.825 86.8%
0.04 0.450 0.390 86.7%
2 0.111 0.54 0.651 0.614 94.3%
0.04 0.151 0.136 90.1%
Precision:
1 . The intra-assay precision was determined from the mean of 10 replicates each.
Sample N Mean(ug/dL)
Standard
Deviation
(ug/dL)
Coefficient
of Variation
(%)
H 10 0.897 0.01 3.88%
M 10 0.51 0.03 6.22%
L 10 0.14 0.01 7.12%
2. The inter-assay precision was determined from the mean of average duplicates for ten
separate runs.
Sample N
Mean
(ug/dL)
Standard
Deviation
(ug/dL)
Coefficient
of Variation
(%)
H 10 0.538 0.04 6.69%
L 10 0.129 0.01 6.88%
Linearity of Dilution: Three saliva samples were diluted with PBS and assayed.
Dilution
Sample Factor
Expected
Factor
Expected
(ug/dL)
Observed
(ug/dL)
Recovery
(%)
1
0.513
1:2 0.256 0.271 105.8%
1:4 0.128 0.134 104.7%
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1:8 0.64 0.057 89%
1:16 0.032 0.036 112.5%
1:32 0.016 0.015 93.8%
0.141
1:2 0.071 0.068 95.8%
1:4 0.035 0.035 100%
1:8 0.018 0.020 111.1%
0.387
1:2 0.193 0.199 103.1%
1:4 0.097 0.100 103.1%
1:8 0.048 0.054 112.5%
1:16 0.024 0.023 95.8%
1:32 0.012 0.011 97.7%
Sensitivity: The lower limit of sensitivity was determined by interpolating the mean minus 2SD
for 10 sets of duplicates at 0 ug/dL standard. The minimal concentration of cortisol that can be
distinguished from 0 is <.007 ug/dL.
Correlation with Serum: The correlation between serum and saliva cortisol was determined by
assaying 19 matched samples using the Diagnostic Products Corporation serum Coat-a-Count
Cortisol RIA and the Salimetrics HS Salivary Cortisol EIA.
The correlation between saliva and serum was highly significant, r (17) = 0.960, p < 0.0001
.
Seller's Limited Warranty
"Seller warrants that all goods sold hereunder will be free from defects in material and
workmanship. Upon prompt notice by Buyer of any claimed defect, which notice must be sent
within thirty (30) days from date such defect is first discovered and within six months from the
date of shipment, Seller shall, at its option, either repair or replace the product that is proved to
Seller's satisfaction to be defective. This warranty does not cover any damage due to accident,
misuse, negligence, or abnormal use.
It is expressly agreed that this limited warranty shall be in lieu of all warranties of
fitness
and in lieu of the warranty of merchantability. Seller shall not be liable for any incidental
or
consequential damages that arise out of the installation, use or operation of Seller s
product or out of the breach of any express or implied warranties."
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Cortisol Specificity
In the HS Salivary Cortisol EIA, the following compounds were tested at concentrations up to
66,000 ng/ml_ for cross-reactivity.
Compound Spiked
Concentration(Ng/mL)
% Cross-reactivityin
HS Salivary Cortisol
EIA
Prednisolone 100 09.530
Prednisone 1000 0.421
Cortisone 1000 0.31
11-Deoxycortisol 500 3.116
21-Deoxycortisol 1000 0.745
1 7-a Hydroxy-
progesterone
1000 0.611
Dexamethasone 1000 1.277
Triamcinolone 1000 0.430
Corticosterone 10,000 0.093
Progesterone 1000 00.060
DHEA 10,000 ND
Testosterone 10,000 ND
Transferrin 66,000 ND
Aldosterone 10,000 ND
ND = non-detectable (<0.004)
53
APPENDIX E
DEMOGRAPHICS QUESTIONS
a) Gender: Male Female
b) What is your ethnic/racial group?
Asian/Asian American or Pacific Islander
African/African American
Latino/Hispanic (e.g., Cuban, Puerto Rican, Mexican)
Native American
White/Caucasian
Other_
c) Date of Birth
d) AGE
e) Using the scale below, what is your mother’s highest level of education?
_High School or trade school
_Some College
_College graduate
_Some graduate school
_Graduate degree (masters, doctorate, or professional degree)
f) Using the scale below, what is your father’s highest level of education?
_High School or trade school
_Some College
_College graduate
_Some graduate school
_Graduate degree (masters, doctorate, or professional degree)
g) What is your mother’s occupation?
full-time part-time unemployed
h) What is your father’s occupation?
full-time part-time unemployed
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APPENDIX F
CES-D
The statements on this page arc about how people feel sometimes. Please put an
“X” to indicate the number of days you have felt that way in the last week. Include
today as part of that week.
During the Past Week: Rarely A little Moderate Most
(Less than
1 day) (
1 to 2 days) (3-4 days) (5-7 days)
1 . I was bothered by things that usually
don’t bother me.
2. 1 did not feel like eating; my appetite
was poor.
3. 1 felt that I could not shake off the
blues even with help from my family and
friends.
4. 1 felt that I was just as good as other
people.
5. 1 had trouble keeping my mind on
what 1 was doing.
6. 1 felt depressed.
7. 1 felt that everything 1 did was an
effort.
8. I felt hopeful about the future.
9. 1 thought that my life had been a
failure.
10. I felt fearful.
1 1 . My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. 1 had crying spells.
18. I felt sad.
19. 1 felt that people disliked me.
20. I could not get going.
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APPENDIX G
TRAUMA SYMPTOM CHECKLIST - 40
How often have you experienced each of the following in the last two months?
1 ) Headaches
Never
0 1 2
Often
3
2) Insomnia (trouble eettine to sleep! 0 1 2 3
3) Weight loss (without dieting) 0 1 2 3
4) Stomach problems 0 1 2 3
5) Sexual problems 0 1 2 3
6) Feeling isolated from others 0 1 2 3
7) "Flashbacks" (sudden, vivid, distracting memories) 0 1 2 3
8) Restless sleep 0 1 2 3
9) Low sex drive 0 1 2 3
1 0) Anxietv attacks 0 1 2 3
1 1 ) Sexual overactivity 0 1 2 3
1 2) Loneliness 0 1 2 3
13) Nightmares 0 1 2 3
14) "Soacine out" (eoine awav in vour mind) 0 1 2 3
15) Sadness 0 1 2 3
1 6) Dizziness 0 1 2 3
1 7) Not feeling satisfied with your sex life 0 1
2 3
1 8) Trouble controlline vour temper 0 1 2 3
1 9) Waking up early in the morning and can't get back to sleep
0 1 2 3
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TSC-40 continued
—
P-2—
**How often have you experienced each of the following in the last two months?
Never Often
20) Uncontrollable erving 0 1 2 3
2 1 ) Fear of men 0 1 2 3
22) Not feeline rested in the morning 0 1 2 3
23) Having sex that you didn't enjoy 0 1 2 3
24) Trouble eetting alone with others 0 1 2 3
25) Memory problems 0 1 2 3
26) Desire to nhvsicallv hurt vourself 0 1 2 3
27) Fear ofwomen 0 1 2 3
28) Waking up in the middle of the night 0 1 2 3
29) Bad thoughts or feelings during sex 0 1 2 3
30) Passing out 0 1 2 3
3 1 ) Feeling that things are "unreal" 0 1 2 3
32) Unnecessary or over-freauent washing 0 1 2 3
33) Feelings of inferiority 0 1 2 3
34) Feeline tense all the time 0 1 2 3
35) Being confused about your sexual feelings 0 1 2 3
36) Desire to phvsicallv hurt others 0 1 2 3
37) Feelings of guilt 0 1 2 3
38) Feelines that vou are not alwavs in vour body 0 1 2 3
39) Having trouble breathing 0 1
2 3
40) Sexual feelines when vou shouldn't have them 0 1 2 3
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APPENDIX H
SELF-INJURY QUESTIONNAIRE
Sometimes people engage in behaviors that are harmful to their bodies. These
behaviors are sometimes accidental, and sometimes intentional. Please answer these
questions with respect to intentional behavior. Please indicate when was the last
time you engaged in such behavior, as well as the frequency with which the behavior
has occurred over your lifetime. If ’’never” please choose this option.
1 . Have you ever engaged in any behavior that was deliberately harmful to your body?
(i.e. you harmed yourself on purpose
.)
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
2. Have you ever intentionally engaged in behavior that produced bruising?
Frequency:
a) None
b)
c)
d)
e)
0
one time in my life
between 2-5 times in my life
between 6-10 times in my life
between 1 1-20 times in my life
over 20 times in mv life
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
3 . Have you ever deliberately hit yourself?
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
Frequency:
a) None
b) one time in my life
c) between 2-5 times in my life
d) between 6-10 times in my life
e) between 1 1 -20 times in my life
f) over 20 times in my life
Frequency:
a) None
b) one time in my life
c) between 2-5 times m my life
d) between 6-10 times in my life
e) between 1 1 -20 times in my life
f) over 20 times in my life
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4.
Have you ever intentionally pulled out your hair or eyelashes?
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
0 over 1 year ago (within 5 years)
g) over 5 years ago
Frequency:
a) None
b) one time in my life
c) between 2-5 times in my life
d) between 6-10 times in my life
e) between 1 1-20 times in my life
0 over 20 times in my life
5.
Have you ever purposely scratched yourself with fingernails or other objects hard
enough to leave marks or cause bleeding?
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
Frequency:
a) None
b) one time in my life
c) between 2-5 times in my life
d) between 6-10 times in my life
e) between 11-20 times in my life
0 over 20 times in my life
6.
Have you ever deliberately bit yourself hard enough to leave marks?
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
Frequency:
a) None
b) one time in my life
c) between 2-5 times in my life
d) between 6-10 times in my life
e) between 1 1-20 times in my life
f) over 20 times in my life
7.
Have you ever purposely eaten toxic substances or sharp objects?
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
Frequency:
a) None
b) one time in my life
c) between 2-5 times in my life
d) between 6-10 times in my life
e) between 1 1 -20 times in my life
f) over 20 times in my life
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8. Have you ever intentionally burned
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
0 over 1 year ago (within 5 years)
g) over 5 years ago
cigarette, match, or other?
Frequency:
a) None
b) one time in my life
C) between 2-5 times in my life
d) between 6-10 times in my life
e) between 1 1-20 times in my life
f) over 20 times in my life
yourself with a lit
9. Have you ever purposely cut or gouged yourself with a razor blade, broken glass, or
other?
Most recent Time:
a) Never
b) in the past week
c) in the past month
d) in past 6 months
e) in the past year
f) over 1 year ago (within 5 years)
g) over 5 years ago
Frequency:
a) None
b) one time in my life
c) between 2-5 times in my life
d) between 6-10 times in my life
e) between 1 1 -20 times in my life
0 over 20 times in my life
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APPENDIX I
TABLES
Table 1. Descriptive statistics and sex differences in psychopathology variables
Variables Men Women
skew kurtosis range tN Mean SD N Mean SD
TSC-40 85 23.26 10.59 85 28.42 11.22 .21 -0.20 53.00 -3.09***
CES-D 85 10.18 6.72 85 10.64 7.06 1.07 1.03 35.00 -.043
SIB
weighted
85 48.09 122.55 85 46.39 118.62 3.40 12.38 770.00 0.09
SIB
severity
85 0.26 0.44 85 0.26 0.44 1.11 -.78 1.00 0.00
SIB
frequency
61 1.02 1.41 62 1.11 1.43 1.14 0.31 5.00 -0.38
SIB
recency
84 0.82 1.32 82 1.00 1.63 1.64 1.99 6.00 -0.77
***p<0.002
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Table 2. Descriptive statistics and sex differences in cortisol variables
Variables Men Women
skew kurtosis range tN Mean SD N Mean SD
Cortisol
Time 1
(ug/dl)
85 0.24 0.15 85 0.21 0.14 2.84 11.57 1.01 1.10
Cortisol
Time 2
(ug/dl)
85 0.29 0.19 85 0.24 0.14 2.34 7.46 1.08 1.96*
Cortisol
Time 3
(ug/dl)
85 0.27 0.17 85 0.25 0.19 2.38 7.90 1.17 0.63
Cortisol
Time 4
(ug/dl)
84 0.24 0.14 85 0.22 0.14 1.65 3.83 0.90 0.53
Cortisol
Time 5
(ug/dl)
85 0.21 0.12 85 0.22 0.15 1.74 3.83 0.73 -0.67
Cortisol
Time 6
(ug/dl)
85 0.18 0.09 85 0.21 0.13 1.33 1.99 0.61 -1.29
Cortisol
Time 7
(ug/dl)
85 0.18 0.09 85 0.20 0.12 1.71 5.64 0.77 -1.34
Cortisol
Reactivity
(ug/dl)
85 0.11 0.15 85 0.09 0.11 2.33 6.82 0.76 0.91
Cortisol
Peak Time
(minutes)
85 27.29
25.2
7
85 28.65 29.00 0.88 -0.17 90.00 -0.32
Cortisol
Recovery
(ug/dl)
85 0.007 0.13 85 0.01 0.12 1.57 6.30 0.96 2.44**
.
*p<0.05 **p<0.02
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Table 5. Pearson correlations of self-injury variables and psychopathology
measures.
Men Women
SIB Measure TSC-40 CES-D TSC-40 CES-I)
SIB
Weighted
0.084
(N=85)
-0.030
(N=85)
0.337**
(N=85)
0.162
(N=85)
SIB
Severity Score
0.171
(N=85)
0.110
(N=85)
0.421***
(N=85)
0.363***
(N=85)
SIB
Frequency
0.164
(N=61)
0.026
(N=62)
0.469***
(N=62)
0.461***
(N=62)
SIB
Recency
0.1 88A
(N=84)
0.001
(N=82)
0.351***
(N=82)
0.286*
(N=82)
Ap<0.09 *p<0.01 **p<0.002 ***p<0.001
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Table 6. Paired T-tests comparing basal and maximum cortisol levels
Variables Men (n=85) Women (n=85)
mean SD t Mean SD t
Basal Cortisol
(ug/dl)
0.24 0.15
-6.90*
0.21 0.14
-7.75*
Maximum Cortisol
(ug/dl)
0.35 0.22 0.31 0.20
*p< 0001
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Table 7. Pearson correlations of cortisol variables and physiological control variables
for men.
Awake
Time
Hours of
Sleep
Anti-
biotic
Advil
-
Tylenol
(old
Meds
Allergy
Meds
Asthma
Mods Alcohol
Basal Cortisol
0.03
(N=84)
0.05
(N=84)
0.06
(N=84)
-0.02
(N=84)
-0.04
(N=84)
0.07
(N=84)
0 16
(N=84)
0.53**
(N=8I
)
Anticipatory
Cortisol
-0.10
(N=84)
-0.14
(N=84)
-0.07
(N=84)
-0.05
(N=84)
0.01
(N=84)
0.25*
(N=84)
0.09
(N=84)
0.28*
(N=8I)
Cortisol Time 3
-0.03
(N=84)
0.12
(N=84)
-0.03
(N=84)
0.03
(N=84)
-0.04
(N=84)
0.42**
(N=84)
0.28*
(N=84)
006
(N=81
)
Cortisol Time 4
-0 01
(N=83)
0.15
(N=83)
-0.07
(N=83)
0.05
(N=83)
0.01
(N=83)
0.35**
(N=83)
0.26*
(N=83)
0.15
(N=8I)
Cortisol Time 5
-0.10
(N=84)
0.03
(N=84)
-0.09
(N=84)
0.03
(N=84)
-0.02
(N=84)
0.39**
(N=84)
0.15
(N=84)
0.12
(N=8 1
)
Cortisol Time 6
-0.04
(N=84)
0.02
(N=84)
-0.07
(N=84)
-0.08
(N=84)
-0.04
(N=84)
0.33**
(N=84)
0.19
(N=84)
0.12
(N=81)
Cortisol Time 7
-0.04
(N=84)
-0.06
(N=84)
-0.03
(N=84)
-0.07
(N=84)
-0.07
(N=84)
0.44**
(N=84)
0.12
(N=84)
0.23*
(N=81)
Cortisol
Reactivity
-0.08
(N=84>
-0.09
(N=84)
-0.08
(N=84)
0.06
(N=84)
001
(N=84)
0.57**
(N=84)
0.11
(N=84)
-0.11
(N=8I)
Cortisol Peak
Time
0.05
(N=84)
0.05
(N=84)
-0.12
(N=84)
-0.09
(N=84)
-0.08
(N=84)
0.12
(N=84)
-0.10
(N=84)
-0.25*
(N=81)
Extent of
recovery
0.07
(N=84)
0.10
(N=84)
0.08
(N=84)
0.02
(N=84)
-0.00
(N=84)
-0.22*
(N=84)
0.10
(N=84)
0.43**
(N=8 1
)
*p<0.05 **p<0.01
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Table 8. Pearson correlations of cortisol variables and physiological control variables
for women.
Awake
Time
Hours
of
Sleep
Anti-
biotic
Birth
Control
Aspirin
Advil/
Tylenol
Cold
Vleds
Allergy
Meds
Asthma
Meds SSRI’s
Basal
Cortisol
-0.07
(N=84)
0.02
(N=84)
0.07
(N=85)
0.02
(N=85)
-0.04
(N=85)
-0.06
(N=85)
0.06
(N=85)
-0.01
(N=85)
-0 04
(N=85)
0J0»*
(N=85)
Anticipatory
Cortisol
-0.03
(N=84)
0.02
(N=84)
0.05
(N=85)
0.11
(N=85)
-0.06
(N=85)
0.00
(N=85)
-0.03
(N=85)
0.21
(N=85)
-0.01
(N=85)
0.16
(N=85)
Cortisol
Time 3
-0.10
(N=84)
-0.02
(N=84)
0.13
(N=85)
0.14
(N=85)
-0.08
(N=85)
-0.06
(N=85)
-0.04
(N=85)
0.1
1
(N=85)
0.00
(N=85)
0.02
(N=85)
Cortisol
Time 4
-0.09
(N=84)
-0.00
(N=84)
0.20
(N=85)
0.22*
(N=85)
-0.09
(N=85)
-0.03
(N=85)
001
(N=85)
0.18
(N=85)
-0.08
(N=85)
0.00
(N=85)
Cortisol
Time 5
-0.04
(N=84)
0.14
(N=84)
0.17
(N=85)
0.12
(N=85)
-0.09
(N=85)
-0.09
(N=85)
-0.01
(N=85)
0.02
(N=85)
-0.04
(N=85)
0.40**
(N=85)
Cortisol
Time 6
-0.1 1
(N=84)
-0.01
(N=84)
0.14
(N=85)
0.21
(N=85)
-0.09
(N=85)
-0.05
(N=85)
0.06
(N=85)
0.08
(N=85)
-0.02
(N=85)
0.1
1
(N=85)
Cortisol
Time 7
-0.04
(N=84)
0.19
(N=84)
0.02
(N=85)
0.15
(N=85)
-0.11
(N=85)
-0.04
(N=85)
0.03
(N=85)
-0.03
(N=85)
-0.02
(N=85)
0.54**
(N=85)
Cortisol
Reactivity
-0.14
(N=84)
-0.04
(N=84)
0.07
(N=85)
0.02
(N=85)
-0.09
(N=85)
-0.09
(N=85)
-0.05
(N=85)
0.20
(N=85)
-0.01
(N=85)
0.23*
(N=85)
Cortisol
Peak Time
-0.06
(N=84)
0.04
(N=84)
-0.09
(N=85)
0.04
(N=85)
-0.11
(N=85)
-0.16
(N=85)
0.05
(N=85)
-0.07
(N=85)
0.04
(N=85)
0.12
(N=85)
Extent of
recovery
-0.05
(N=84)
-0.18
(N=84)
0.07
(N=85)
-0.13
(N=85)
0.07
(N=85)
-0.03
(N=85)
0.04
(N=85)
_
0.02
(N=85)
-0.02
(N=85)
-0.22*
j
(N=85)
*p<0.05 **p<0.01
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Fable 9. Summary of simultaneous regression Analyses for variables predicting
Cortisol Time to Peak reactivity in women (N=82)
Variable B SE B F
SSRIs 61.36 28.39 0.23*
4.43**SIB recency
(K ** - CO
-3.94 1.93 -0.22*
*p<05 **p<02
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Table 10. Summary of simultaneous regression analyses for variables predicting
cortisol time to peak reactivity in women controlling for depressive and trauma
symptoms (N=82)
Variable B SE 11 F
SSRIs 54.79 30.20 0.205*
2.38**
CES-D 0.37 0.54 0.09
TSC-40 -0.25 0.33 -0.10
SIB recency -3.68 2.06 -0.20*
*p<.08 **p<.06
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Table 1 1 . Summary of simultaneous regression analyses assessing trauma as a
moderator of the relation between self-injury and anticipatory cortisol levels in
women (N=85)
Variable B SE ft F
Allergy meds 0.28 0.14 0.22*
2.60**
SSRIs 0.22 0.14 0.17
SIB-weighted -0.0001 0.000 -0.09
TSC-40 0.0005 0.001 0.04
TSC*SIBcont 0.00002 0.000 0.323**
*p<.05 **p<.04
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Table 12. Summary of simultaneous regression analyses assessing trauma as a
moderator of the relation between self-injury and time of peak eortisol levels in
women (N=85)
Variable B SE 11 F
Allergy meds -21.84 28.75 -0.08
1.83A
SSRIs 61.38 28.64 0.23**
SIB-weighted 0.058 0.04 0.23
TSC-40 -0.29 0.31 -0.11
TSC*SIBcont -0.004 0.002 -0.26*
Ap<0.11 *p<0.09 **p<0.04
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I able 13. Summary of simultaneous regression analyses assessing depression as a
moderator of the relation between self-injury and basal cortisol levels in women
(N=85)
Variable B SE B 1
Allergy meds 0.012 0.14 0.01
2.45*
SSRIs 0.43 0.15 0.33**
SIB-weighted 0.00008 0.00 0.07
CES-D -0.0008 0.002 -0.04
CESD*SIBcont 0.000043 0.00 0.218*
*p<05 **p<01
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Table 14. Summary ol simultaneous regression analyses assessing depression as a
moderator of the relation between self-injury and anticipatory cortisol levels in women
(N=85)
Variable B SE 0 F
Allergy meds 0.30 0.14 0.23**
2.59**
SSRIs 0.28 0.15 0.21*
SIB-weighted 0.00015 0.000 0.12
CES-D -0.0011 0.002 -0.06
CESD*SIBcont 0.000048 0.000 0.24**
*p<.07 **p<.04
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Figure 1. Mean cortisol levels by sex across time points
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Figure 2. Women's trauma symptoms moderate the relation between self-injury
scores and the time to peak cortisol level.
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Figure 3. Women’s trauma symptoms moderate the relation between self-injury
scores and anticipatory cortisol level (ug/dl).
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Figure 4. Women’s depression symptoms moderate the relation between self-injury
scores and basal cortisol levels (ug/dl).
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Figure 5. Women’s depression symptoms moderate the relation between self-injury
scores and anticipatory cortisol levels (ug/dl).
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